A detailed history of Heritage Family Offices, LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Heritage Family Offices, LLP holds 1,927 shares of LLY stock, worth $1.6 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
1,927
Previous 1,942 0.77%
Holding current value
$1.6 Million
Previous $1.76 Billion 2.9%
% of portfolio
0.88%
Previous 0.98%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$772.14 - $960.02 $11,582 - $14,400
-15 Reduced 0.77%
1,927 $1.71 Billion
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $1.41 Million - $1.77 Million
1,942 New
1,942 $1.76 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $791B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Heritage Family Offices, LLP Portfolio

Follow Heritage Family Offices, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Family Offices, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Family Offices, LLP with notifications on news.